MedPath

桂林华诺威基因药业股份有限公司

Ownership
-
Established
1999-08-31
Employees
-
Market Cap
-
Website
www.pavay.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

6

NMPA:6

Drug Approvals

Diquafosol Sodium Eye Drops

Product Name
地夸磷索钠滴眼液
Approval Number
国药准字H20253192
Approval Date
Jan 14, 2025
NMPA

Human Epidermal Growth Factor Eye Drops

Product Name
易贝
Approval Number
国药准字S20143010
Approval Date
Aug 8, 2020
NMPA

Human Epidermal Growth Factor Gel

Product Name
易孚
Approval Number
国药准字S20020113
Approval Date
Aug 8, 2020
NMPA

Human Epidermal Growth Factor Gel

Product Name
易孚
Approval Number
国药准字S20020112
Approval Date
Aug 8, 2020
NMPA

Human Epidermal Growth Factor Eye Drops

Product Name
易贝
Approval Number
国药准字S20020016
Approval Date
Aug 8, 2020
NMPA

Human Epidermal Growth Factor Gel

Product Name
易孚
Approval Number
国药准字S20020111
Approval Date
Aug 8, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.